13F

Stock

Relmada Therapeutics, Inc.

RLMD · held by 2 managers

Reported value

$51.6K

Holders

2

+0 new · −0 exited

Holders’ est. mark

−$21.4K

Price effect on 2 books still in the name

Largest holder

$33.5K

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC14.8K$33.5K−$11.6KAdded$633
Leonteq Securities AG8K$18.1K−$9.84KCut−$9.84K

Positions as of Q1 2023. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.